rabezol 10ml inj
otsira - rabezole sodium - inj - 20mg - 10ml
pramexol 1mg tablet
medispec (m) sdn.bhd - pramipexole dihydrochloride monohydrate -
pramexol 0.25mg tablet
medispec (m) sdn.bhd - pramipexole dihydrochloride monohydrate -
praxole xr pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 2.25 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; silicon dioxide; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 3.75 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; hypromellose; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.75 mg - tablet, modified release - excipient ingredients: magnesium stearate; hypromellose; silicon dioxide; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: hypromellose; silicon dioxide; calcium hydrogen phosphate; magnesium stearate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 4.5 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; hypromellose; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 3 mg - tablet, modified release - excipient ingredients: magnesium stearate; silicon dioxide; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
praxole xr pramipexole dihydrochloride monohydrate 0.375 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.375 mg - tablet, modified release - excipient ingredients: hypromellose; calcium hydrogen phosphate; magnesium stearate; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.